HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruediger Erdmann Selected Research

1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate

11/2006Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruediger Erdmann Research Topics

Disease

1Adenocarcinoma
11/2006
1Neoplasms (Cancer)
11/2006

Drug/Important Bio-Agent (IBA)

11L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonateIBA
11/2006
1lipoplatinIBA
11/2006
1Cisplatin (Platino)FDA LinkGeneric
11/2006
1PlatinumIBA
11/2006
1Proteins (Proteins, Gene)FDA Link
11/2006
1A-Form DNA (A-DNA)IBA
11/2006